| Issue |
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
|
|
|---|---|---|
| Page(s) | 850 - 852 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2025215 | |
| Published online | 12 December 2025 | |
L’interféron de type III amplifie l’activation des cellules dendritiques plasmacytoïdes par TLR7 et bloque l’action inhibitrice de TGFβ et PGE2
Type III interferon primes plasmacytoid dendritic cells for TLR7 activation to overcome TGFβ- and PGE2- mediated inhibition
Centre de recherche en cancérologie U1052, Université Claude Bernard Lyon 1, Lyon, France
*
This email address is being protected from spambots. You need JavaScript enabled to view it.
**
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cet article ne possède pas de résumé.
© 2025 médecine/sciences – Inserm
Article publié sous les conditions définies par la licence Creative Commons Attribution License CC-BY (https://creativecommons.org/licenses/by/4.0), qui autorise sans restrictions l’utilisation, la diffusion, et la reproduction sur quelque support que ce soit, sous réserve de citation correcte de la publication originale.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
